VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1651781
Sex: F
Age:
State: MN

Vax Date: 05/06/2021
Onset Date: 05/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 06May2021 at 09:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06May2021 at 20:00 the patient experienced tinnitus which started the evening she received the vaccine and has continued ever since. It was reported to be all the time. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the event tinnitus was not resolved/ongoing at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651782
Sex: F
Age:
State: TX

Vax Date: 04/20/2021
Onset Date: 05/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Lump/knot in armpit area on same arm as shot; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 20Apr2021 at 14:00 (at the age of 39-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 11May2021 at 18:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06May2021 at 07:00, the patient experienced lump/knot in armpit area on the same arm as shot. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event lump/knot in armpit area was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651783
Sex: F
Age:
State: VA

Vax Date: 03/09/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: PET scan; Result Unstructured Data: Test Result:UNSPECIFIED RESULT; Comments: Patient reported that on report date (14May2021) she had received her PET scan result which sowed that lymphoma in her rectum was gone.

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: First of all, What I am going to report is not the adverse effect of the vaccine. Instead it is the good effect of the vaccine. I was diagnosed as Malt Lymphoma in Sept. 2019. I believe the two doses of the Pfizer vaccine cured my lymphoma.; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 09Mar2021 at 13:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 30Mar2021 at 13:30(at the age of 68-year-old) as a dose for COVID-19 immunisation. Medical history included malt lymphoma. The patient received unspecified medication within two weeks of vaccination. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient has experienced unexpected therapeutic benefit from both the doses. On an unknown date the patient reports that "first of all", what she reported was not the adverse effect of the vaccine. Instead, it was the good effect of the vaccine. The patient was diagnosed with malt lymphoma on an unknown date in Sep2019. The patient believed that the two doses of Pfizer vaccine cured her lymphoma. On the report date(14May2021) she got her latest PET scan result which showed that lymphoma in her rectum was gone. She has never had any treatment for the lymphoma. The only symptom she had been had was the tender/pain in the lymphoma location in her lower ab. After the first dose of vaccine, she could feel that the pain was reduced. The patient developed multiple lymph nodes swollen, shortness of the breath, and night sweat etc. which were typical lymphoma symptoms after the second dose of the vaccine. At the same time, the pain at the lower ab had been significantly reduced. Also, her appetite had been improved a lot which made her to gain 4 lbs since 30Mar. This means a lot to the patient since she had lost the appetite and kept losing weight in the last few years. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. On an unknown date, the patient underwent positron emission tomography (PET) scan which showed that lymphoma in her rectum was gone. The clinical outcome of the event unexpected therapeutic benefit was recovered on an unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651784
Sex: U
Age:
State: FL

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Date: 20210318; Test Name: Palpitations; Result Unstructured Data: Test Result:128 to 133; Comments: severe palpitations of 128 to 133; Test Date: 20210509; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Sob/very sob at rest position; Palpitations/severe palpitations of 128 to 133; Severe skin rash was developed through my arms,legs, belly and under chin neck and upper arms; Skind feels like sand paper; This is a spontaneous report from a contactable other HCP. A 56-year-old other HCP (patient) of unknown gender reported that received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number EN 6208), intramuscular into the left arm on 17Mar2021 at 09:15 AM (at the age of 56-years-old) at single dose for COVID-19 immunization. the patient had no known allergies. Medical history included High bp. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant drugs were unknown. 24 hrs from first dose of vaccine on 18Mar2021 at 08:00 AM, severe skin rash developed through the arms, legs, belly and under chin neck and upper arms. Causing sob and palpitations. The patient got an appointment with primary care Dr and he asked not to do 2nd dose and the patient did not took. At he time of reporting as almost 2 months from vaccine day and the patient still presented sob symptoms, also rash on legs, arms and neck has considerably increasing, further also skin feels like sand paper. Had an emergency room visit due to severe palpitations of 128 to 133. Also very sob at rest position After the patient followed up with primary order more meds and lab test. The events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient was treated with Pills and creams. The reporter considered the events as non serious. The outcome of the events was not recovered. Covid Nasal Swab post vaccination done on 09May2021 was negative.

Other Meds:

Current Illness:

ID: 1651785
Sex: F
Age:
State:

Vax Date: 05/01/2021
Onset Date: 05/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Elevated heart rhythm; fever; chills; sensitive skin; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 01May2021 at 15:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ibuprofen (ADVIL) and ibuprofen (MOTRIN) both from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm left on 08Apr2021 at 13:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 02May2021 at 04:00, the patient experienced Elevated heart rhythm, fever, chills and sensitive skin. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events Elevated heart rhythm, fever, chills and sensitive skin were recovered on an unknown date in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds: ADVIL [IBUPROFEN]; MOTRIN [IBUPROFEN]

Current Illness:

ID: 1651786
Sex: F
Age:
State: MO

Vax Date: 05/13/2021
Onset Date: 05/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Injection site tenderness; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 1261) via an unspecified route of administration in the right arm on 13May2021 at 09:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included borderline personality disorder and sleep apnea. Concomitant medications included desvenlafaxine succinate monohydrate (PRISTIQ), quetiapine fumarate (SEROQUEL XR) and zolpidem tartrate (AMBIEN) all for unspecified indications from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 1261) via an unspecified route of administration in the left arm on 22Apr2021 at 09:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13May2021, at 14:30 the patient experienced injection site tenderness. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event injection site tenderness was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PRISTIQ; SEROQUEL XR; AMBIEN

Current Illness:

ID: 1651787
Sex: F
Age:
State: CT

Vax Date: 05/06/2021
Onset Date: 05/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: bright red and pink; was sick for 2 days; joints and bones ached; Fever; joints and bones ached; back ache; This is a spontaneous report from a contactable consumer (parent). A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 06May2021 18:30 (at the age of 45 years old) as dose 2, single for COVID-19 immunisation. Medical history included underactive thyroid. No investigation assessment. Concomitant medication(s) included levothyroxine (LEVOTHYROXINE) taken for thyroid disorder from an unspecified start date and ongoing. Patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on Apr2021 (at the age of 45 years old) as single for COVID-19 immunisation and experienced sore arm. The patient experienced fever, joints and bones ached, back ache, bright red and pink, was sick for 2 days on 06May2021. Reported as, reporter mentioned daughter who had the shot and was sick for 2 days. This was with the second vaccination, she had the Pfizer. All of her symptoms, fever, joints and bones aching, back ache and being bright red and pink, lasted 2 days. Outcome of all the events were recovered on May2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1651788
Sex: F
Age:
State:

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Finger numbness; Underarm pain; Chest pain; Swollen lymph nodes; Feverish after 2 weeks; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW1076) via an unspecified route of administration in the left arm on 01May2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis. Concomitant medications included vitamins (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and diphenhydramine, paracetamol, phenylpropanolamine hydrochloride (BENADRYL); all from an unknown dates, for an unknown indications, unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP5733) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01May2021 the patient experienced finger numbness, underarm pain, chest pain, swollen lymph nodes and feverish. It was unknown whether any therapeutic measures were taken as a result of the reported events. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events of finger numbness, underarm pain, chest pain, swollen lymph nodes and feverish were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA; BENADRYL

Current Illness:

ID: 1651789
Sex: F
Age:
State: PA

Vax Date: 05/10/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: hot flashes; Night sweats; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8736) via an unspecified route of administration in the arm left on 10May2021 at 15:15(at the age of 54-years-old)as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included estrogens conjugated, medroxyprogesterone acetate (PREMPRO), omeprazole magnesium (OMEPRAZOLE), multivitamins (Unspecified) and acetylsalicylic acid (BABY ASPIRIN) all for unknown indications and from unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0161) via an unspecified route of administration in the arm left on 19Apr2021 at 15:15(at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021, the patient experienced hot flashes and night sweats. The patient reported that she were previously managed the events by pempro and events were returned. Therapeutic measures were taken as a result of hot flashes and night sweats and included treatment with prempro ongoing at the time of report. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency department or urgent care. The clinical outcome of the events hot flashes and night sweats was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PREMPRO; OMEPRAZOLE; BABY ASPIRIN

Current Illness:

ID: 1651790
Sex: F
Age:
State: GA

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Migraine-like headaches, concentrated in occipital/neck area; This is a spontaneous report from a contactable healthcare professional, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 03May2021 at 13:00 as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications included diclofenac potassium (MANUFACTURER UNKNOWN) for an unknown indication, from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on an unknown date of Apr2021 at 12:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 14:00, the patient experienced migraine-like headaches, concentrated in occipital/neck area. The patient had migraine-like headaches, concentrated in occipital/neck area, beginning and early afternoon each day and lasting into the evening. Symptoms had begun the day following vaccination and had persisted every day (10 days) after, with no resolve. The patient did not regularly suffer from headaches. No therapeutic measures were taken as result of the event. The clinical outcome of the event migraine-like headaches, concentrated in occipital/neck area was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: DICLOFENAC POTASSIUM

Current Illness:

ID: 1651791
Sex: M
Age:
State:

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Approximately 8 hours after administration of second vaccine, patient began to feel chills; Approximately 8 hours after administration of second vaccine, patient began headache; Approximately 8 hours after administration of second vaccine, patient began nausea; This is a spontaneous report from a non-contactable consumer. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via intramuscular route of administration in the left arm on an unknown date in May2021 as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included vitamins (unspecified) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via intramuscular route of administration in the left arm on an unknown date in Apr2021 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in May2021, approximately 8 hours after administration of second vaccine, the patient began to feel chills, headache and nausea that lasted approximately 10 hours. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events feel chills, headache and nausea were recovered on an unknown date in May2021 (lasted approximately 10 hours). No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651792
Sex: M
Age:
State:

Vax Date: 05/13/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: I started to smell burnt bacon and coffee; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in the left arm on 13May2021(at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history included Adhd and stress. Concomitant medications included adhd medication and stress medication. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14May2021 the patient started to smell burnt bacon and coffee. No therapeutic measures were taken as a result of reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event started to smell burnt bacon and coffee was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651793
Sex: F
Age:
State: WI

Vax Date: 05/13/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210514; Test Name: Body temperature; Result Unstructured Data: Test Result: adverse event: Fever of 101

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Body aches; Fever of 101; Chills; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 15-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0168) via an unspecified route of administration in the left arm on 13May2021 at 14:30 (at the age of 15-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included salbutamol (ALBUTEROL) for unspecified indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 05:00, the patient experienced fever of 101, body aches, chills, nausea for 12 hours, commencing 15 hrs after vaccine. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the events. On 14May2021 at 05:00, the patient underwent body temperature test and the result was fever of 101. The clinical outcome of the events fever of 101, body aches, chills, nausea was resolved on 14May2021 at 17:00. No follow-up attempts are needed. No further information is expected.

Other Meds: ALBUTEROL [SALBUTAMOL]

Current Illness:

ID: 1651794
Sex: F
Age:
State: WA

Vax Date: 05/12/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210512; Test Name: Body temperature; Result Unstructured Data: Test Result:Between 99.7 - 100.8

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Muscle tightness in upper back (shoulders); soreness in upper back (shoulders); Headache; Mild fever ranging between 99.7 - 100.8 degreesFahrenheit; Lower back pain/muscle soreness; Lower back muscle soreness; Chills; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 12May2021 at 14:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 19Apr2021 at 14:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021, the patient experienced chills at around 16:00 lasting approx. 15 minutes, lower back pain/muscle soreness at 16:30, headache and mild fever ranging between 99.7 - 100.8 degrees Fahrenheit at 2100 and significant muscle tightness/soreness in upper back (shoulders) at 21:30. Headache lasted till 14May2021 and ultimately took naproxen which alleviated it and has not returned. All other symptoms were resolved by 13May2021. On 12May2021 patient underwent lab test which include body temperature and the result was ranging between 99.7 - 100.8 degrees Fahrenheit. Therapeutic measures were taken as a result of headache and included treatment with naproxen (MANUFACTURER UNKNOWN). No therapeutic measures were taken for other events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of chills was recovered at 16:15 on 12May2021, mild fever, muscle tightness/soreness in upper back (shoulders) and lower back pain/muscle soreness were recovered on 13May2021 and headache was recovered on 14May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651795
Sex: M
Age:
State: CA

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: "Dose number one given 26Jan2021/ Dose number two given 11Feb2021 I dont think enough time passed to take second dose"; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 11Feb2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included COVID-19. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient previously received the first dose BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EL9262) in the left arm on 26Jan2021 at 09:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 11Feb2021, the patient reported that dose number one was given on 26Jan2021 and dose number two was given on 11Feb2021. The patient reported that he did not think enough time had passed to take the second dose. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651796
Sex: F
Age:
State: AL

Vax Date: 05/11/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: chest tightness; slight wheezing; total head/body aches; total head/body aches; skin very sensitive/tender; skin very sensitive/tender; chills; Injection site extremely tender for 5-7 days; rash all over body; This is a spontaneous report from a contactable Nurse (patient). A 53-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171), intramuscular, administered in left arm on 11May2021 at 10:00 (at the age of 53-years-old) as dose 2, single for COVID-19 immunisation. The patient previously received first dose of bnt162b2 (lot number EL9263) on 20Apr2021 and experienced total head/body aches, skin very sensitive/tender, chills and injection site extremely tender. Medical history included high blood pressure (BP), depression, high cholesterol and COVID (Prior to vaccination). Concomitant medications included metoprolol succinate, candesartan, vilazodone hydrochloride (VIIBRYD), estradiol, amlodipine besylate, bupropion, hctz, atorvastatin, amylase/ascorbic acid/cellulase/folic acid/lipase/protease nos (JUICE PLUS), cyanocobalamin (B12), fish oil (OMEGA 3) and apoaequorin/colecalciferol (PREVAGEN) taken. On 11May2021 at 16:00 the patient experienced total head/body aches, skin very sensitive/tender, chills, injection site extremely tender for 5-7 days, rash all over body, and slight wheezing. On 13May2021 the patient experienced chest tightness. The events resulted in Doctor or other healthcare professional office/clinic visit. The events were treated with Benedryl and anti itch cream. Since the vaccination, the patient was not tested for COVID-19. The outcome of events was recovering.; Sender's Comments: Based on the closet temporal relationship and known drug safety profile, the association between the reported events with BNT162b2 cannot be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: METOPROLOL SUCCINATE; CANDESARTAN; VIIBRYD; ESTRADIOL; AMLODIPINE BESYLATE; BUPROPION; HCTZ; ATORVASTATIN; JUICE PLUS; B12 [CYANOCOBALAMIN]; OMEGA 3 [FISH OIL]; PREVAGEN [APOAEQUORIN;COLECALCIFEROL]

Current Illness:

ID: 1651797
Sex: F
Age:
State: IL

Vax Date: 04/15/2021
Onset Date: 05/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: chills, body aches after second dose; chills, body aches after second dose; This is a spontaneous report from a contactable consumer, patient. A 49-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0168) via an unspecified route of administration in the left arm on 15Apr2021(at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient did not have any known allergies to food, medication or other product. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep6955) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07May2021 at 16:00, the patient experienced chills, body aches after second dose. There were no symptoms after first dose. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills and body ache were recovered on unknown date in 2021 at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651798
Sex: F
Age:
State: FL

Vax Date: 04/27/2021
Onset Date: 04/30/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: rash; swelling in hands; develop hives all over body (flare) on day 3; inflammation; This is a spontaneous report from a contactable consumer (patient herself). A 40-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 27Apr2021 14:00 (Batch/Lot number was not reported) at the age of 40 years, as dose 2, single for COVID-19 immunisation. Medical history included undifferentiated connective tissue disease (UCTD) from an unknown date and unknown if ongoing. There were no concomitant medications. The patient received no other medications within 2 weeks of vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 06Apr2021 (Batch/Lot number was not reported) as dose 1 for COVID-19 immunization and experienced rash and swelling in hands. The patient was not diagnosed with COVID-19 prior to vaccination. On 30Apr2021, the patient experienced rash and swelling in hands and developed hives all over body (flare) on day 3. The patient have been on steroid for 7 days to decrease inflammation but it was not going away. The events resulted in resulted in doctor or other healthcare professional office/clinic visit. Treatment included steroids (methylprednisolone)/ antihistamine. The outcome of the events was recovering. The patient had not been tested for COVID-19 since the vaccination. The lot number for the vaccine BNT162B2 , was not provided and will be requested during follow-up.

Other Meds:

Current Illness:

ID: 1651799
Sex: F
Age:
State: WV

Vax Date: 05/13/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Rash in splotches all over body except head/neck on the day after receiving vaccine, it spread into bigger splotches and new splotches; This is a spontaneous report from a contactable consumer, the patient. A 15-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0153) via an unspecified route of administration in the left arm on 13May2021 at 15:30 (at the age of 15-years-old) as a single dose for COVID-19 immunisation. Medical history included "Adhd". The patient had no known allergies. Concomitant medications included cetirizine hydrochloride (ZYRTEC). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 02:00, on the day after receiving, the patient experienced rash in splotches all over body except head/neck, the second day on 15May2021, it spread into bigger splotches and new splotches. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event rash in splotches all over body except head/neck on the day after receiving vaccine, it spread into bigger splotches and new splotches was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1651800
Sex: F
Age:
State: NC

Vax Date: 05/12/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: After 55 hours I got chills, a fever, severe vomiting for about an hour.; After 55 hours I got chills, a fever, severe vomiting for about an hour.; After 55 hours I got chills, a fever, severe vomiting for about an hour.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12May2021 at 13:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included appendectomy 8 years ago. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 12:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 23:00, after 55 hours the patient got chills, a fever, severe vomiting for about an hour. The patient could not think of any other reason this would have happened so she wanted to tell because it seemed long after the shot. The patient felt perfectly fine until then. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events after 55 hours the patient got chills, a fever, severe vomiting for about an hour was resolving at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1651801
Sex: F
Age:
State: SC

Vax Date: 05/06/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: COVID-19 virus test; Test Result: Positive ; Comments: Prior to the vaccination, the patient was diagnosed with COVID-19; Test Date: 20210319; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Rash on chest; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0150) via an unspecified route of administration in the arm right on 06May2021 at 14:00 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included barrett's esophagus, COVID-19 and rash on chest 10 days after the patient recovered from the virus in Nov2020. The patient previously took AVALOX on an unknown date and experienced allergy. Concomitant medications included esomeprazole sodium (NEXIUM), aluminium hydroxide gel, dried, magnesium carbonate (PEPCID), loratadine (CLARITIN) from unknown date and unknown if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient underwent nasal swab and the result was negative. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0158) via an unspecified route of administration in the arm left on 15Apr2021 at 14:30 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. On 14May2021, at 18:00, 10 days after second dose, the patient developed a rash on chest. Therapeutic measures were taken as a result of event and included treatment with anti-itch cream from unspecified date. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event rash on chest was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NEXIUM [ESOMEPRAZOLE SODIUM]; PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]; CLARITINE

Current Illness:

ID: 1651802
Sex: F
Age:
State: NE

Vax Date: 05/10/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Cough/second day I feel like I have been getting worse I have a cough chest pain rib pain and difficulty breathing nausea and migraines; Chest pain/ second day I feel like I have been getting worse I have a cough chest pain rib pain and difficulty breathing nausea and migraines; Rib pain/second day I feel like I have been getting worse I have a cough chest pain rib pain and difficulty breathing nausea and migraines; Difficulty breathing / second day I feel like I have been getting worse I have a cough chest pain rib pain and difficulty breathing nausea and migraines; Nausea / second day I feel like I have been getting worse I have a cough chest pain rib pain and difficulty breathing nausea and migraines; Migraines / second day I feel like I have been getting worse I have a cough chest pain rib pain and difficulty breathing nausea and migraines; First day of second dose I was fine just a mild headache; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the arm right on 10May2021 at 12:45 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the arm right on 19Apr2021 at 13:00 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11May2021, first day of second dose the patient was fine just a mild headache. But after the second day on 12May2021, the patient felt like she had been getting worse had a cough, chest pain, rib pain, difficulty breathing, nausea, and migraines. The patient had been taking cough medicine but was not working. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of cough which include treatment with medicine unspecified. The clinical outcome of the events just a mild headache, had a cough, chest pain, rib pain, difficulty breathing, nausea, and migraines were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651803
Sex: F
Age:
State: CT

Vax Date: 05/13/2021
Onset Date: 05/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Strong headache starting around 6pm (approximately 3 hours after shot); Sore arm around injection site starting about an hour after shot; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old, non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 13May2021 at 15:00 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 13May2021 at 16:00, the patient experienced sore arm around injection site which started about an hour after the shot which continued through the next day. On 13May2021 around 18:00, the patient experienced a strong headache (approximately 3 hours after shot). On 13May2021, in the evening of the vaccination day and the day after the shot, the patient experienced fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events sore arm around injection site and fatigue. Therapeutic measures were taken as a result of the event strong headache which included treatment with over the counter (OTC) TYLENOL and headache went away in a few hours. The clinical outcome of events sore arm around injection site, strong headache and fatigue was resolved on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651804
Sex: F
Age:
State: NY

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: got a pain started out feeling like mid back pain, and became more of a chest pain. It was an aching and stabbing pain heavy to the chest.; got a pain started out feeling like mid back pain, and became more of a chest pain. It was an aching and stabbing pain heavy to the chest.; got a pain started out feeling like mid back pain, and became more of a chest pain. It was an aching and stabbing pain heavy to the chest.; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the arm right on 04May2021 at 08:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, asthma, depression, anxiety, thyroid disorder, scoliosis and penicillin allergy. Concomitant medications included levothyroxine sodium (SYNTHROID), bupropion hydrochloride (WELLBUTRIN), methylphenidate hydrochloride (RITALIN), solifenacin succinate (VESICARE) and tiotropium bromide monohydrate (SPIRIVA); all from unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm right on 13Apr2021 at 08:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 14:00, the following day after the shot, about 30 hours after shot, the patient started out feeling like mid back pain and became more of a chest pain. The patient fell asleep for two hours and was woken up by the chest pain worsening. Lasted about four hours. It was an aching and stabbing pain heavy to the chest. Therapeutic measures were taken as a result of the events and included treatment with 325 ASPIRIN. The clinical outcome of the events got a pain started out feeling like mid back pain, became more of a chest pain and aching and stabbing pain heavy to the chest was recovered on 05May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID; WELLBUTRIN; RITALIN; VESICARE; SPIRIVA

Current Illness:

ID: 1651805
Sex: F
Age:
State: IL

Vax Date: 04/07/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Period was delayed by 5 days (33 days in the cycle); This is a spontaneous report from a contactable consumer, the patient. This is the first of two reports. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EW0158), via an unspecified route of administration in the left arm on 07Apr2021 at 15:30 (at the age of 38-years-old), as a single dose for COVID-19 immunization. The patient had no medical history. The patient did not have any allergies to medications, food or other products. Concomitant medications included multivitamins and cod-liver oil. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On unknown date, the patient experienced period was delayed by 5 days (33 days in the cycle) after the first dose. The patient mentioned that regular cycle length was 26 days. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event period was delayed by 5 days (33 days in the cycle) was unknown at the time of reporting. No follow-up attempts were needed. No further information was expected.

Other Meds: FISH OIL

Current Illness:

ID: 1651806
Sex: F
Age:
State: NC

Vax Date: 03/30/2021
Onset Date: 04/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Moderate to severe joint pain, particularly in hands, but also hips, elbows; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 12:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included triglycerides high. The patient did not have any allergies to medications, food, or other products Concomitant medications included omega-3-acid ethyl ester (LOVAZA), BCP (UNKNOWN MANUFACTURER), Ipatroprium NS (UNKNOWN MANUFACTURER), mefenamic acid (ADVIL), curcuma longa (TURMERIC), colecalciferol, retinol (VITA) all from unknown dates and for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 11Mar2021 at 12:00 (at the age of 56-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 the patient experienced moderate to severe joint pain, particularly in hands, but also hips, elbows. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event severe joint pain, particularly in hands, but also hips, elbows was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: LOVAZA; ADVIL [MEFENAMIC ACID]; TURMERIC [CURCUMA LONGA]; VITA [ASCORBIC ACID;COLECALCIFEROL;RETINOL]; IPRATROPIUM

Current Illness:

ID: 1651807
Sex: F
Age:
State: CA

Vax Date: 05/13/2021
Onset Date: 05/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Had difficulty focusing and concentrating; had shaking in my hands; chills; Hot flashes; eventually leading to muscle aches; swelling of my left arm.; swelling of left leg; heaviness in my left arm; lethargy; easily fatigued; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 13May2021 at 10:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 22Apr2021 at 10:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13May2021 at 12:45, within two hours of receiving the second dose, the patient experienced difficulty in focusing and concentrating, had shaking in hands that could not be stopped, chills, hot flashes which eventually led to muscle aches on the left side of the body, swelling of left arm and left leg, heaviness in left arm and lethargy/easily fatigued. The worst pain was between 23:00 and 06:00 of next day, which was about 12 hours after the shot. The patient also reported that he did not have symptoms after the first dose. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events difficulty in focusing and concentrating, shaking in hands, chills, hot flashes, muscle aches on the left side of the body, swelling of left arm and left leg, heaviness in left arm and lethargy/easily fatigued were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651808
Sex: M
Age:
State: TX

Vax Date: 05/13/2021
Onset Date: 05/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: had very little soreness the first day. WhenI woke up the next day, my arm hurtvery badly.; nausea; dizziness; chills mild; feverish feeling; moderate fatigue; had a very mild sharp, needle-like pain.; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13May2021 at 14:45 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13May2021 at 14:45, the patient experienced a very mild sharp, needle-like pain. On 14May2021, the patient experienced arm hurt very badly. Throughout the day had moderate fatigue. Also, had nausea, dizziness, chills, and a feverish feeling all those symptoms were mild. Patient also stated he had a light, protein-filled dinner that night. Therapeutic measures were taken as a result of the events and included treatment with TYLENOL 325 mg. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events arm hurt very badly, moderate fatigue, nausea, dizziness, chills, and a feverish feeling was recovered on an unspecified date in May2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651809
Sex: M
Age:
State: MD

Vax Date: 04/01/2021
Onset Date: 04/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Itchy rash at site of injection; Itchy rash at site of injection; itchy rash on right lower back, right thigh and behind left knee and back of left thigh; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 65-years-old), as a single dose for COVID-19 immunisation. Medical history included inflammatory bowel disease and known allergies to bananas and raspberries. The patient received unspecified medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 11Mar2021 (at the age of 65-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, the patient experienced itchy rash at site of injection and on right lower back, right thigh and behind left knee and back of left thigh. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event itchy rash at site of injection and on right lower back, right thigh and behind left knee and back of left thigh was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651810
Sex: F
Age:
State: WA

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: I have had severely worsened anxiety; I have had severely worsened anxiety, new panic attacks Ive never had before,; Daily headaches; Waves of extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 18Mar2021 at 18:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and depression. The patient did not have any allergies to medications, food, or other products. Concomitant medications included oral birth control nos (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18Mar2021, the patient experienced severely worsened anxiety, new panic attacks she had never had before, daily headaches, and waves of extreme fatigue. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events anxiety, panic attacks, headaches and fatigue was not resolved/ongoing at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 09Apr2021 at 18:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds: ORAL CONTRACEPTIVE NOS

Current Illness:

ID: 1651811
Sex: M
Age:
State: MN

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Muscle Pain at injection site; Joint pains; feeling of heat around body; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14May2021 at 13:00(at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergic to gluten. Concomitant medications included quetiapine fumarate (SEROQUEL) 200mg from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 22:00, the patient experienced muscle pain at injection site, joint pains, feeling of heat around body and fatigue. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events muscle pain at injection site, joint pains, feeling of heat around body and fatigue was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: SEROQUEL

Current Illness:

ID: 1651812
Sex: F
Age:
State: MN

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Pain; acheness; light headed; weak; nausea; severe pain in arm; cold; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14May2021 at 15:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. Concomitant medications included methotrexate (MANUFACTURER UNKNOWN), amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL) and folic acid (MANUFACTURER UNKNOWN) all from unknown date for unspecified indications. The patient did not have a history of allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 17:45 the patient experienced pain, achiness, light headed, weak, nausea, severe pain in arm and cold. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcomes of the events pain, achiness, light headed, weak, nausea, severe pain in arm and cold was not recovered at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: METHOTREXATE; ADDERALL; FOLIC ACID

Current Illness:

ID: 1651813
Sex: F
Age:
State: MN

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210514; Test Name: Body temperature; Result Unstructured Data: Test Result:104; Comments: developed a fever that got up to over 104 degrees

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: developed a fever; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the left arm on 14May2021 at 09:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no allergies to medications, food, or other products. Concomitant medications included ibuprofen (ADVIL), taken from an unknown date for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 09:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 19:30, about 10 hours after vaccination, the patient developed a fever that got up to over 104 degrees. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event fever was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ADVIL [IBUPROFEN]

Current Illness:

ID: 1651814
Sex: F
Age:
State: CO

Vax Date: 05/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Light headed; vision changes; Neck pain; Ear pain; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15May2021 at 11:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient included chronic pain, depression and anxiety. The patient received other medications in two weeks, and was unspecified. The patient previously took Neosporin and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Apr2021 at 11:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 12:45, the patient experienced light headed and vision changes, neck pain and ear pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events light headed, vision changes, neck pain and ear pain were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651815
Sex: M
Age:
State: FL

Vax Date: 05/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210515; Test Name: Nasal Swab; Result Unstructured Data: Test Result: UNKNOWN RESULTS

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: idk; This is a spontaneous report from a contactable consumer, the patient. A 15-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15May2021 at 15:30 (at the age of 15-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any medications within two weeks of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 15May2021, the patient reported that he experienced "idk". On 15May2021, the patient underwent a nasal swab test, the results of which were not known. It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of the event "idk" was unknown at the time of this report. No follow up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651816
Sex: M
Age:
State:

Vax Date: 05/12/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Vertigo / hangover-like symptoms; hangover-like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12May2021 at 15:00(at the age of 30-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 14:00(at the age of 30-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14May2021 at 12:00 after 3-4 days of second dose, the patient experienced vertigo / hangover-like symptoms. The symptoms was lasted at least 24 hours. The patient reported that he had no medical history of vertigo or onset dizziness prior to vaccination. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event vertigo and hangover-like symptoms was resolved on 15May2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651817
Sex: F
Age:
State: CA

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210515; Test Name: Pulse rate; Result Unstructured Data: Test Result:150 bpm; Test Date: 20210515; Test Name: Body temperature; Result Unstructured Data: Test Result:99.7 Units:[degF]; Comments: 99.7 F

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Racing pulse (150 bpm); Fever (99.7 F); Body aches; Pain at site of surgery within past years; Dry mouth; Loss of taste; Loss of smell; Soreness at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167), via an unspecified route of administration in the left arm on 14May2021 at 10:15 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history included major depression, tenosynovial giant cell tumor and soft tissue inflammation of the back and neck. The patient had known allergies to penicillin, zolpidem tartrate (AMBIEN), walnuts and pecans. Concomitant medications included sertraline hydrochloride (ZOLOFT), cyclobenzaprine hydrochloride (FLEXERIL), ibuprofen (MANUFACTURER UNKNOWN) and fluticasone propionate (FLONASE); all from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729), via an unspecified route of administration in the left arm on 20Apr2021 at 12:00, as a single dose for COVID-19 immunisation. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 00:00, the patient experienced racing pulse (150 bpm), fever (99.7 F), body aches, pain at site of surgery within past years, dry mouth, loss of taste, loss of smell and soreness at injection site. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 15May2021 at 00:00, the patient underwent lab test and procedures which included body temperature and the result was 99.7 F and for pulse rate the result was 150 bpm. The clinical outcome of the events racing pulse (150 bpm), fever (99.7 F), body aches, pain at site of surgery within past years, dry mouth, loss of taste, loss of smell and soreness at injection site were resolving at the time of reporting. No follow-up attempts are possible. No further information is expected.

Other Meds: ZOLOFT; FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE]; IBUPROFEN; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1651818
Sex: F
Age:
State: WA

Vax Date: 05/07/2021
Onset Date: 05/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Feet/calves feeling heavy. Mostly affecting left side of body. Comes and goes randomly.; Waves of vertigo; Waves of tingling in lips, face, and extremities; Waves of tingling in lips, face, and extremities; During a spell, weak grip in hand; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the right arm on 07May2021 at 09:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included hay fever (seasonal hay fever) and penicillin allergy. Concomitant medications included ascorbic acid, pyridoxal phosphate, thiamine hydrochloride, riboflavin sodium phosphate, calcium pantothenate, adrenal cortical extract, glycyrrhiza glabra root, zinc bis glycinate chelate, adrenal gland (CORTREX), vitamin D nos (MANUFACTURER UNKNOWN) and calcium (MANUFACTURER UNKNOWN) all for unknown indications and since an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13May2021, 6 days after vaccination, the patient experienced waves of vertigo, waves of tingling in lips, face, and extremities. During a spell, weak grip in hand. Feet/calves feeling heavy. Mostly affecting left side of body. Comes and goes randomly. The patient had been resting and may seek out medical care if it persists. The patient did not receive any treatment for the events. The clinical outcome of the events vertigo, waves of tingling in lips, face, and extremities, weak grip in hand, feet/calves feeling heavy were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D [VITAMIN D NOS]; CALCIUM; CORTREX

Current Illness:

ID: 1651819
Sex: M
Age:
State: CA

Vax Date: 04/29/2021
Onset Date: 05/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: rashes like hives on body.; Severe itching; swelling; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 29Apr2021 at 15:00 (at the age of 35-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 13:00, the patient developed rashes like hives on body, severe itching and swelling. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with tropical cream. The clinical outcome of the events rashes like hives on body, severe itching and swelling was not recovered at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1651820
Sex: F
Age:
State: NV

Vax Date: 04/23/2021
Onset Date: 04/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Increasing daily dizziness over the course of first and second week. Third week in and less frequent and much more mild dizziness.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 23Apr2021 at 16:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any other medical history. The patient had no known allergies to medications, food, or other products. Other medication within two weeks of vaccination was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021 at 14:00, the patient experienced increasing daily dizziness over the course of first and second week. Third week in and less frequent and much more mild dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event increasing daily dizziness over the course of first and second week, third week in and less frequent and much more mild dizziness was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651821
Sex: F
Age:
State: MO

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210515; Test Name: Rapid testing; Test Result: Negative

Allergies:

Symptom List: Pain in extremity

Symptoms: headache; migraine; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) in the left arm on 24Mar2021 at 10:00 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included duloxetine hydrochloride (CYMBALTA) for unspecified indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 10:00 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. On 24Mar2021 at 13:00, the patient experienced headache and migraine. The patient had been having continuous daily headaches and sometimes so bad as migraines ever since receiving the vaccine. The patient underwent lab tests and procedures which included rapid testing for COVID-19 on 15May2021 and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with sumatriptan. The clinical outcome for the events continuous daily headaches and sometimes so bad as migraines were not recovered at the time of reporting. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: CYMBALTA

Current Illness:

ID: 1651822
Sex: F
Age:
State: FL

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Nausea; General Body pain; Vomiting; Muscle pain; fatigue; Headcahe; Joint pain; was freezing; then burning up; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Ew0175) via an unspecified route of administration in the left arm on 14May2021 at 11:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis. The patient had no known allergies. Concomitant medications included birth control daily (UNSPECIFIED) and hydroxyzine (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0153 ) via an unspecified route of administration in the left arm on 23Apr2021 at 11:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 the patient felt fine until about 12 hours after the second vaccine. The patient woke up at 00:30 and experienced nausea and pain all over her body, vomited for the following 12 hours and could not keep down food or liquids, no fever but she had freezing and then burning up. 29 hours since the vaccine, the patient felt moderately joint pain, muscle pain especially in the back of her neck, fatigue, nausea and severe headache. The patient did not receive any treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events general body pain, nausea, vomiting, joint pain, freezing, burning up, muscle pain, fatigue and headache was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROXYZINE

Current Illness:

ID: 1651823
Sex: F
Age:
State: SC

Vax Date: 04/28/2021
Onset Date: 05/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: after second shot followed by itchy rash forming on both forearms and spreading over several days to shoulders, neck and legs.; Massive headache; night sweats; body aches; pains; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 16:45(at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included vitamin d nos (VITAMIN D) and magnesium sulfate (MAGNESIUM), all from unknown dates and for unknown indications. The patient previously received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 16:45(at the age of 56-year-old) as a single dose for COVID-19immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10May2021 at 02:00, the patient experienced massive headache, night sweats, body ache and pains. On 11May2021, the patient experienced itchy rash forming on both forearms and spreading over several days to shoulders, neck and legs. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events which included treatment with herbal supplements to relieve effects. The clinical outcome of the event massive headache, night sweats, body aches, pains and itchy rash on both forearms, shoulders, neck and legs was recovering at the time of this report No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: VITAMIN D [VITAMIN D NOS]; MAGNESIUM

Current Illness:

ID: 1651824
Sex: F
Age:
State: CA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210413; Test Name: Nasal swab; Test Result: Negative.

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: fatigued; dizzy; slight shortness of breath; face cheeks and tongue felt numb; face cheeks and tongue felt numb; tingling sensation; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 13Apr2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included positive Purified Protein Derivative (PPD) test and migraine with aura. The patient was allergic to bee stings. Concomitant medications included fluoxetine hydrochloride (PROZAC), taken for an unspecified indication from an unknown date. The patient previously took vicodin and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13Apr2021 at 18:00, 6 hours after the first dose, the patient felt fatigued, dizzy, slight shortness of breath and face, cheeks and tongue felt numb. The event resulted in emergency room/department or urgent care. At the emergency room, the patient was told that it was tingling sensation and not numbness since he was able to move the tongue. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen. On 13Apr2021, the patient underwent COVID-19 test (nasal swab) in the emergency room and the result was negative. The clinical outcome of the events fatigued, dizzy, slight shortness of breath and numb/tingling at face, cheeks and tongue were resolved on unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: PROZAC

Current Illness:

ID: 1651825
Sex: F
Age:
State: FL

Vax Date: 05/13/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Bloody nose; Randomly began bleeding vaginally, although it is not that time of the month.; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the arm left on 13May2021 at 20:00 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included systemic scleroderma. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received no past drug or medication. On 15May2021 at 09:00, the patient randomly began bleeding vaginally, although it was not that time of the month and this evening the patient got a bloody nose. No therapeutic measures were taken as a result of the adverse event. The clinical outcome of the events randomly began bleeding vaginally, although it was not that time of the month and bloody nose were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651826
Sex: F
Age:
State: TN

Vax Date: 05/13/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Supraclavicular nodal swelling, left side; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 13May2021 at 12:00 (at the age of 14-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medication included ibuprofen (ADVIL) for unspecified indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 15May2021 at 12:00, the patient experienced supraclavicular nodal swelling, left side. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event supraclavicular nodal swelling, left side was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: ADVIL [IBUPROFEN]

Current Illness:

ID: 1651827
Sex: F
Age:
State: VA

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Immediately following the shot became lightheaded.; developed a headache.; small diameter flesh colored hives on face, neck and torso.; Scratching itchy areas left bright red marks onbody.; Scratching itchy areas left bright red marks onbody.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 14May2021 at 13:30 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Medical history included allergic reaction/ once elevated autoimmune urticaria markers ("normal now" as reported at the time of reporting), fruit allergy and meat allergy. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), clonazepam (KLONOPIN), zinc (MANUFACTURER UNKNOWN) and calcium gluconate, magnesium gluconate, potassium chloride (BIO CMP); all for unspecified indication from unknown date. The patient previously took moxifloxacin hydrochloride (AVELOX), levofloxacin (LEVAQUIN), hydrocortisone (CORTISOL) and glycyrrhiza glabra (LICORICE); all for unspecified indication from unknown date and experienced drug allergy to moxifloxacin hydrochloride (AVELOX), levofloxacin (LEVAQUIN), hydrocortisone (CORTISOL) and glycyrrhiza glabra (LICORICE). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021, immediately following the shot, the patient became lightheaded and developed a headache . On 14May2021 at 15:00, within a few hours, the patient experienced small diameter flesh colored hives on face, neck and torso and scratching itchy areas left bright red marks on body. Over 24 hours later, and hives/bumps were still present and body was itchy. No throat swelling or large red raised bumps/welts. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event immediately following the shot became lightheaded, developed a headache, small diameter flesh colored hives on face, neck and torso, scratching itchy areas left bright red marks on body was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: GABAPENTIN; KLONOPIN; ZINC; BIO CMP

Current Illness:

ID: 1651828
Sex: F
Age:
State: MI

Vax Date: 04/22/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Swollen lymph node; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on 22Apr2021 and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on 13May2021 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis and allergy induced asthma. The patient had no known allergies. Concomitant medications included probiotics (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D) 50,000u 1x per week , 25xannax (MANUFACTURER UNKNOWN) on an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 00:00, 4 days after first dose, the patient had notice one swollen lymph node on the right side of her neck. It was still swollen for second dose. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph node was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 1651829
Sex: F
Age:
State: AZ

Vax Date: 04/30/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210502; Test Name: Pain scale; Result Unstructured Data: Test Result:Headache ranged from a 2-6 on pain scale; Test Date: 20210501; Test Name: Body temperature; Result Unstructured Data: Test Result:b/w 101-102 for the next 12 hrs; Test Date: 20210501; Test Name: Body temperature; Result Unstructured Data: Test Result:100.4 Units:{DF}; Comments: at 07:00

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Was made worse by coughing; Head rushes; Sunday I was just really tried w/ headache/ I thenproceeded to have a headache for a full 2 weeks. Headache ranged from a 2-6 on pain scale; Fever of 100.4/ Fever remained b/w 101-102 for the next 12 hrs; Body aches; Fatigue.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 46-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: WAG 03657) via an unspecified route of administration in the right arm on 30Apr2021 at 14:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), sulfamethoxazole, trimethoprim (BACTRIM), gliclazide (CLARITIN) and fluticasone propionate (FLONASE); all from an unknown date for unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: WAG 03657), via an unspecified route of administration in the right arm on 02Apr2021 at 16:30 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01May2021 at 07:00, following 2nd shot the next morning, the patient woke up with fever of 100.4 and body aches. Fever remained between 101-102 for the next 12 hours with body aches and fatigue. The patient took 2 naproxen (ALEVE) at 8pm which resolved fever and body aches within a couple of hours. On 02May2021, Sunday the patient was just really tried with headache. She then proceeded to had a headache for a full 2 weeks. Her headache ranged from a 2-6 on pain scale and was made worse while coughing or bending over. She had head rushes for the first week when ever going from sit to stand. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of fever and body aches which included treatment with 2 naproxen (ALEVE) at 8pm on 01May2021. No therapeutic measures were taken as a result of remaining events. The clinical outcome of fever of 100.4/ fever remained between 101-102 and body aches were recovered on 01May2021. The clinical outcome of coughing, fatigue, headache and head rushes were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: WELLBUTRIN; BACTRIM; CLARITIN [GLICLAZIDE]; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1651830
Sex: F
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 04/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Muscles on the left side of face felt tense; About 72 hours ((afternoon of 4/19) after thevaccination) started to feel a numbness in the left side of face, from chin up to undereye area; About 72 hours ((afternoon of 4/19) after thevaccination) started to feel tingling sensation in the left side of face, from chin up to undereye area; The left side of face hurts; Face almost like it bruised; Approximately 48 hours after the vaccination, started feeling a slight numbness in left arm; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the arm left on 16Apr2021 at 14:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, eczema and allergy to tree nuts. Concomitant medication included drospirenone, ethinylestradiol betadex clathrate (YAZ) from unknown date as birth control and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 12:00, approximately 48 hours after the vaccination, the patient started feeling a slight numbness in left arm. On 19Apr2021, about 72 hours after, in the afternoon, the numbness from arm was still there, and the patient also started to feel a numbness/tingling sensation in the left side of face, from chin up to undereye area. It felt similar to when come off of numbing after a cavity filling at the dentist. That evening, the numbness in arm and face had still not subsided and when touched the left side of face hurt, almost like it felt bruised. On 20Apr2021, muscles on the left side of face felt tense, when smiled it felt like there was resistance on the left side of face vs. the right. This improved gradually over the following weeks, but have some residual muscle tenseness at the time of this report (15May2021). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events approximately 48 hours after the vaccination, started feeling a slight numbness in left arm, about 72 hours ((afternoon of 4/19) after the vaccination) started to feel a numbness in the left side of face, from chin up to undereye area, about 72 hours ((afternoon of 4/19) after the vaccination) started to feel tingling sensation in the left side of face, from chin up to undereye area, the left side of face hurts were recovered with sequalae on 20Apr2021 , the patient was recovered with sequalae from the event face almost like it bruised on an unknown date in 2021. The patient was not recovered from the event muscles on the left side of face felt tense at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: YAZ

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am